1. TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma
   Soji Toda et al, 2022, Cancers CrossRef
2. DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
   Emma Andersson Evelönn et al, 2019, BMC Cancer CrossRef
3. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer
   Rui-qiong Ma et al, 2018, Archives of Gynecology and Obstetrics CrossRef
4. Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF
   Sumit Bhattacharyya et al, 2016, PLOS ONE CrossRef
5. A phase 2 study of glembatumumab vedotin, an antibody‐drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma
   Patrick A. Ott et al, 2019, Cancer CrossRef
6. Increased GPNMB, phospho-ERK1/2, and MMP-9 in cystic fibrosis in association with reduced arylsulfatase B
   Sumit Bhattacharyya et al, 2018, Molecular Genetics and Metabolism CrossRef
7. GPNMB overexpression is associated with extensive bone metastasis and poor prognosis in renal cell carcinoma
   Jian-Po Zhai et al, 2021, Oncology Letters CrossRef
8. Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer
   April A.N. Rose et al, 2017, Pharmacology & Therapeutics CrossRef
9. Integrated glycoproteomic characterization of clear cell renal cell carcinoma
   T. Mamie Lih et al, 2023, Cell Reports CrossRef